Lifetime Cost of Ischemic Stroke in Germany: Results and National Projections From a Population-Based Stroke Registry: The Erlangen Stroke Project
暂无分享,去创建一个
Bernhard Neundörfer | Martin Emmert | Peter L. Kolominsky-Rabas | Oliver Schöffski | P. Heuschmann | P. Kolominsky-Rabas | O. Schöffski | Peter U. Heuschmann | M. Emmert | Daniela Marschall | Nikoline Baltzer | Karl J. Krobot | K. Krobot | B. Neundörfer | D. Marschall | Nikoline Baltzer
[1] B. Norrving,et al. Costs of Stroke in Sweden A National Perspective , 1994, Stroke.
[2] H. Adams. The importance of the Helsingborg declaration on stroke management in Europe , 1996, Journal of internal medicine.
[3] W M O'Fallon,et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. , 1996, Stroke.
[4] P. Sandercock,et al. Long‐term Survival After First‐Ever Stroke: The Oxfordshire Community Stroke Project , 1993, Stroke.
[5] N. Solomon,et al. Prevalence of stroke and stroke-related disability. Estimates from the Auckland stroke studies. , 1997, Stroke.
[6] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[7] Tx Station. Stata Statistical Software: Release 7. , 2001 .
[8] C. Sudlow,et al. Comparing stroke incidence worldwide: what makes studies comparable? , 1996, Stroke.
[9] Jeroen N. Struijs,et al. International Comparison of Stroke Cost Studies , 2004, Stroke.
[10] J. McNeil,et al. Cost of Stroke in Australia From a Societal Perspective: Results From the North East Melbourne Stroke Incidence Study (NEMESIS) , 2001, Stroke.
[11] M. Knapp,et al. Costs and disability among stroke patients. , 1999, Journal of public health medicine.
[12] P. Heuschmann,et al. A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. , 1998, Stroke.
[13] J. Huisman. The Netherlands , 1996, The Lancet.
[14] J. Caro,et al. Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis Group. , 2000, Stroke.
[15] J. McNeil,et al. Lifetime Cost of Stroke Subtypes in Australia: Findings From the North East Melbourne Stroke Incidence Study (NEMESIS) , 2003, Stroke.
[16] G. L. Engel,et al. Cost of stroke in The Netherlands from a societal perspective. , 1997, Stroke.
[17] Martin McKee,et al. Health care systems in transition , 2002 .
[18] J. Struijs,et al. Modeling the Future Burden of Stroke in the Netherlands: Impact of Aging, Smoking, and Hypertension , 2005, Stroke.
[19] M. Kaste,et al. Economic burden of stroke and the evaluation of new therapies. , 1998, Public health.
[20] D. Cox,et al. A General Definition of Residuals , 1968 .
[21] G. Boysen,et al. COSTS OF HEALTH CARE AND SOCIAL SERVICES DURING THE FIRST YEAR AFTER ISCHEMIC STROKE , 1999, International Journal of Technology Assessment in Health Care.
[22] B. Westling,et al. Utilization of health care resources after stroke. A population‐based study of 258 hospitalized cases followed during the first year , 1991, Acta neurologica Scandinavica.
[23] Impact of urinary incontinence after stroke: results from a prospective population-based stroke register. , 2005, The Journal of urology.
[24] Martin McKee,et al. The economic consequences of non-communicable diseases and injuries in the Russian Federation. Copenhagen, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies. , 2007 .
[25] John F. Forbes,et al. The Cost of Stroke to the National Health Service in Scotland , 1992 .
[26] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[27] R. M. Cruse,et al. A National Perspective , 1991 .
[28] H. C. Hillmann,et al. Statistisches Jahrbuch Für die Bundesrepublik Deutschland 1952 , 1953 .
[29] H. Akaike. A new look at the statistical model identification , 1974 .
[30] K. Huybrechts,et al. Long term cost-of-illness in stroke: an international review. , 2002, PharmacoEconomics.
[31] S. Hatano,et al. Experience from a multicentre stroke register: a preliminary report. , 1976, Bulletin of the World Health Organization.
[32] P. Heuschmann,et al. Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes: Results From a Population-Based Case-Control Study , 2001, Stroke.
[33] Olaf Gefeller,et al. Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long-Term Survival in Ischemic Stroke Subtypes: A Population-Based Study , 2001, Stroke.
[34] G. Hankey,et al. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations* , 1999, The Lancet.
[35] B. Norrving,et al. Direct Costs of Stroke for a Swedish Population , 1990, International Journal of Technology Assessment in Health Care.
[36] J. Habbema,et al. Costs of medical care after first-ever stroke in The Netherlands. , 1995, Stroke.